标题
Tocilizumab: is there life beyond anti-TNF blockade?
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
Volume 65, Issue 4, Pages 508-513
出版商
Wiley
发表日期
2011-01-28
DOI
10.1111/j.1742-1241.2010.02612.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases
- (2010) Fabiola Atzeni et al. AUTOIMMUNITY REVIEWS
- Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions
- (2010) Norihiro Nishimoto et al. Modern Rheumatology
- The Role of Anti–Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?
- (2010) Paul Chapman et al. SEMINARS IN ONCOLOGY
- Long-Term Effects of Rituximab in Rheumatoid Arthritis
- (2009) Luca Quartuccio et al. Annals of the New York Academy of Sciences
- Methotrexate: the gold standard without standardisation
- (2009) J. Kay et al. ANNALS OF THE RHEUMATIC DISEASES
- Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry
- (2009) X Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry)
- (2009) J Augustsson et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
- (2009) G. Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
- (2009) A Finckh et al. ANNALS OF THE RHEUMATIC DISEASES
- Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
- (2009) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor α therapies: Does the risk change with the time since start of treatment?
- (2009) Johan Askling et al. ARTHRITIS AND RHEUMATISM
- The TNF superfamily in 2009: new pathways, new indications, and new drugs
- (2009) Malú G. Tansey et al. DRUG DISCOVERY TODAY
- Available therapeutic options following failure of a first anti-TNF agent
- (2009) Alan J Silman Nature Reviews Rheumatology
- Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
- (2009) Jean-Michel Dayer et al. RHEUMATOLOGY
- Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity
- (2009) K. L. Hyrich et al. RHEUMATOLOGY
- Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-α, Oncostatin M and response to biologic therapies
- (2009) Ellen M Moran et al. ARTHRITIS RESEARCH & THERAPY
- Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis
- (2008) S M van der Kooij et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study
- (2008) N Nishimoto et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research
- (2008) C Salliot et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
- (2008) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events
- (2008) J P Leombruno et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study
- (2008) Mark C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Non-response to infliximab may be due to innate neutralizing anti-tumour necrosis factor-α antibodies
- (2008) E. C. Ebert et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Adalimumab response in patients with early versus established rheumatoid arthritis: DE019 randomized controlled trial subanalysis
- (2008) Shahin Jamal et al. CLINICAL RHEUMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started